Literature DB >> 16370945

Transdermal iontophoresis.

Priya Batheja1, Batheja Priya, Rashmi Thakur, Thakur Rashmi, Bozena Michniak, Michniak Bozena.   

Abstract

Iontophoresis is a technique used to enhance the transdermal delivery of compounds through the skin via the application of a small electric current. By the process of electromigration and electro-osmosis, iontophoresis increases the permeation of charged and neutral compounds, and offers the option for programmed drug delivery. Interest in this field of research has led to the successful delivery of both low (lidocaine) and high molecular drugs, such as peptides (e.g., luteinising hormone releasing hormone, nafarelin and insulin). Combinations of iontophoresis with chemical enhancers, electroporation and sonophoresis have been tested in order to further increase transdermal drug permeation and decrease possible side effects. In addition, rapid progress in the fields of microelectronics, nanotechnology and miniaturisation of devices is leading the way to more sophisticated iontophoretic devices, allowing improved designs with better control of drug delivery. Recent successful designing of the fentanyl E-TRANS iontophoretic system have provided encouraging results. This review will discuss basic concepts, principles and applications of this delivery technique.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16370945     DOI: 10.1517/17425247.3.1.127

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  16 in total

1.  Quantitative analysis of iontophoretic drug delivery from micropipettes.

Authors:  D C Kirkpatrick; L R Walton; M A Edwards; R M Wightman
Journal:  Analyst       Date:  2016-03-21       Impact factor: 4.616

2.  Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane.

Authors:  Giacomo Bruno; Thomas Geninatti; R Lyle Hood; Daniel Fine; Giovanni Scorrano; Jeffrey Schmulen; Sharath Hosali; Mauro Ferrari; Alessandro Grattoni
Journal:  Nanoscale       Date:  2015-03-12       Impact factor: 7.790

3.  Insulin therapies: Current and future trends at dawn.

Authors:  Subhashini Yaturu
Journal:  World J Diabetes       Date:  2013-02-15

4.  [Postoperative pain management. Application of an iontophoretic patient-activated transdermal system].

Authors:  S Grond; J Jage; H Van Aken
Journal:  Anaesthesist       Date:  2008-07       Impact factor: 1.041

5.  Solid lipid nanoparticles of guggul lipid as drug carrier for transdermal drug delivery.

Authors:  Praveen Kumar Gaur; Shikha Mishra; Suresh Purohit
Journal:  Biomed Res Int       Date:  2013-08-24       Impact factor: 3.411

6.  Continuous electrical current and zinc sulphate administered by transdermal iontophoresis improves skin healing in diabetic rats induced by alloxan: morphological and ultrastructural analysis.

Authors:  Lucas Langoni Cassettari; Pedro Colli Rocha Dias; Amanda Natália Lucchesi; Maurício Ferraz de Arruda; Erika Veruska Paiva Ortolan; Mariângela Esther A Marques; César Tadeu Spadella
Journal:  J Diabetes Res       Date:  2014-08-28       Impact factor: 4.011

7.  The Efficacy and Safety of the Fentanyl Iontophoretic Transdermal System (IONSYS®) in the Geriatric Population: Results of a Meta-Analysis of Phase III and IIIb Trials.

Authors:  Eugene R Viscusi; Li Ding; Loretta M Itri
Journal:  Drugs Aging       Date:  2016-12       Impact factor: 3.923

8.  Characterisation and mechanisms of bradykinin-evoked pain in man using iontophoresis.

Authors:  Kathryn J Paterson; Laura Zambreanu; David L H Bennett; Stephen B McMahon
Journal:  Pain       Date:  2013-01-11       Impact factor: 6.961

9.  Effect of duration and amplitude of direct current when lidocaine is delivered by iontophoresis.

Authors:  Susan A Saliba; Courtney L Teeter-Heyl; Patrick McKeon; Christopher D Ingeroll; Ethan N Saliba
Journal:  Pharmaceutics       Date:  2011-12-06       Impact factor: 6.321

Review 10.  Transcutaneous antigen delivery system.

Authors:  Mi-Young Lee; Meong-Cheol Shin; Victor C Yang
Journal:  BMB Rep       Date:  2013-01       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.